Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel nitroxyl-releasing agents synthesized in U.S.

Oct. 21, 2011

Kinagen claims new protein kinase inhibitors

Oct. 21, 2011

Further phase I data reported on GDC-941 in metastatic and advanced cancer

Oct. 21, 2011

Analysis of TIRASMUS data identifies possible marker of temsirolimus efficacy in colorectal cancer

Oct. 21, 2011

German research team presents new cyclin-dependent kinase 9 inhibitors

Oct. 21, 2011

FDA opens Cleveland BioLabs' IND for CBLB-502

Oct. 20, 2011

Viralytics begins enrollment in phase II Cavatak trial following approval for dosing

Oct. 20, 2011

New protein kinase inhibitors presented by GSK

Oct. 20, 2011

Phase II study assessed combination therapy containing rilotumumab in cancer

Oct. 20, 2011

Vandetanib/bicalutamide combination trial does not meet primary endpoint

Oct. 20, 2011

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...